News | 19 August 2012
This week, nine Biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an ?A? (?strong buy?) or ?B? overall (?buy?). Isis Pharmaceuticals (NASDAQ:ISIS) is progressing from last week's rating of B ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)